Korea's drug imports are still ahead of exports from the domestic sector, reports the Ministry of Health and Welfare.
1995 exports reached $474.9 million, six times the level in 1985, and have grown 5.3 times faster than imports in 10 years, but total export volume remained well below 1995's imports of $826.8 million. Moreover, domestic drugmakers have been sluggish in producing high-value-added finished drugs, resulting in a "backward export structure." Finished drugs represented 15.5% of 1995 exports ($63.6 million), compared with $344.4 million for exports of drug raw materials.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze